Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Fossil Group
FOSL
$249M
| $136M | 0.04% |
1,961,617
-6,695
| -0.3% | -$520K |
|
|
MON
502
DELISTED
Monsanto Co
MON
| $136M | 0.04% |
1,275,440
-88,174
| -6% | -$10.2M |
|
503
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
| $136M | 0.04% |
2,579,318
+308,508
| +14% | +$16.3M |
|
504
Weyerhaeuser
WY
$17.2B
| $134M | 0.04% |
4,251,133
+2,572,646
| +153% | +$82.7M |
|
505
CALL
Starbucks
SBUX
$118B
| $133M | 0.04% |
2,489,000
-385,600
| -13% | -$19.6M |
|
|
FL
506
DELISTED
Foot Locker
FL
| $133M | 0.04% |
1,987,356
+588,291
| +42% | +$36.7M |
|
|
BNY
507
Bank of New York Mellon
BNY
$107B
| $133M | 0.04% |
3,170,248
+472,734
| +18% | +$20.1M |
|
508
Mettler-Toledo International
MTD
$27B
| $133M | 0.04% |
388,844
+4,805
| +1% | +$1.58M |
|
509
CALL
Walmart Inc
WMT
$889B
| $133M | 0.04% |
5,609,100
+310,200
| +6% | +$7.91M |
|
510
Terex
TEX
$7.89B
| $133M | 0.04% |
5,700,275
-92,062
| -2% | -$2.43M |
|
511
iShares MSCI Spain ETF
EWP
$2.08B
| $132M | 0.04% |
3,941,949
-447,106
| -10% | -$15.8M |
|
512
PUT
ExxonMobil
XOM
$642B
| $132M | 0.04% |
1,588,300
-13,600
| -0.8% | -$1.17M |
|
513
CALL
Merck
MRK
$323B
| $132M | 0.04% |
2,423,814
+1,150,704
| +90% | +$64.5M |
|
514
Rio Tinto
RIO
$150B
| $131M | 0.04% |
3,182,335
+363,040
| +13% | +$15.9M |
|
515
CALL
IBM
IBM
$204B
| $131M | 0.04% |
841,716
-1,980,497
| -70% | -$318M |
|
516
Pebblebrook Hotel Trust
PEB
$2.19B
| $131M | 0.04% |
3,048,682
-28,184
| -0.9% | -$1.23M |
|
|
APC
517
CALL
DELISTED
Anadarko Petroleum
APC
| $130M | 0.04% |
1,670,300
+286,000
| +21% | +$24.8M |
|
518
HCA Healthcare
HCA
$86.4B
| $130M | 0.04% |
1,435,755
-1,342,296
| -48% | -$108M |
|
519
TSMC
TSM
$2.07T
| $130M | 0.04% |
5,716,658
+1,239,115
| +28% | +$29.6M |
|
520
PUT
Oracle
ORCL
$345B
| $130M | 0.04% |
3,214,500
+1,834,900
| +133% | +$79.6M |
|
521
PUT
AbbVie
ABBV
$454B
| $129M | 0.04% |
1,927,208
+1,387,508
| +257% | +$90.6M |
|
|
MON
522
CALL
DELISTED
Monsanto Co
MON
| $129M | 0.04% |
1,214,600
+898,300
| +284% | +$104M |
|
|
ATML
523
DELISTED
ATMEL CORP
ATML
| $129M | 0.04% |
13,087,695
-2,710,560
| -17% | -$23.9M |
|
524
PUT
CVS Health
CVS
$137B
| $129M | 0.04% |
1,229,100
+716,500
| +140% | +$73.2M |
|
|
SUNE
525
DELISTED
SUNEDISON, INC COM
SUNE
| $129M | 0.04% |
4,307,261
+1,605,857
| +59% | +$45.7M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.